424 related articles for article (PubMed ID: 15335398)
1. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
Møller S; Henriksen JH
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.
Møller S; Bendtsen F; Henriksen JH
Scand J Gastroenterol; 2005 May; 40(5):491-500. PubMed ID: 16036500
[TBL] [Abstract][Full Text] [Related]
3. New treatments of hepatorenal syndrome.
Arroyo V; Terra C; Ginès P
Semin Liver Dis; 2006 Aug; 26(3):254-64. PubMed ID: 16850375
[TBL] [Abstract][Full Text] [Related]
4. Hepatorenal syndrome.
Guevara M; Rodés J
Int J Biochem Cell Biol; 2005 Jan; 37(1):22-6. PubMed ID: 15381144
[TBL] [Abstract][Full Text] [Related]
5. Hepatorenal syndrome.
Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
[TBL] [Abstract][Full Text] [Related]
6. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.
Arroyo V
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402
[TBL] [Abstract][Full Text] [Related]
7. [Hepatorenal syndrome].
Mijac D; Kezić A; Stojimirović B
Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
[TBL] [Abstract][Full Text] [Related]
8. TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?
Gülberg V; Gerbes AL
Z Gastroenterol; 2002 Sep; 40(9):823-6. PubMed ID: 12215953
[TBL] [Abstract][Full Text] [Related]
9. [Physiopathology of refractory ascites and the hepatorenal syndrome].
Arroyo V
Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
[No Abstract] [Full Text] [Related]
10. Treatment of hepatorenal syndrome.
Kiser TH; Maclaren R; Fish DN
Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
[TBL] [Abstract][Full Text] [Related]
11. Therapy insight: Management of hepatorenal syndrome.
Cárdenas A; Ginès P
Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
[TBL] [Abstract][Full Text] [Related]
12. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
Gentilini P; Laffi G; La Villa G; Raggi VC
Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
[TBL] [Abstract][Full Text] [Related]
13. Hepatorenal syndrome.
Biswas KD; Jain AK
Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
[TBL] [Abstract][Full Text] [Related]
14. Hepatorenal syndrome.
Guevara M; Ginès P
Dig Dis; 2005; 23(1):47-55. PubMed ID: 15920325
[TBL] [Abstract][Full Text] [Related]
15. Terlipressin in hepatorenal syndrome: Evidence for present indications.
Rajekar H; Chawla Y
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
[TBL] [Abstract][Full Text] [Related]
16. Hepatorenal syndrome.
Bataller R; Arroyo V; Ginès P; Sort P
Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
[TBL] [Abstract][Full Text] [Related]
17. The management of hepatorenal syndrome.
Carl DE; Sanyal A
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
[TBL] [Abstract][Full Text] [Related]
18. New challenge of hepatorenal syndrome: prevention and treatment.
Wong F; Blendis L
Hepatology; 2001 Dec; 34(6):1242-51. PubMed ID: 11732014
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in hepatorenal syndrome.
Arroyo V; Torre A; Guevara M
Trop Gastroenterol; 2005; 26(1):13-20. PubMed ID: 15974232
[TBL] [Abstract][Full Text] [Related]
20. Fluid retention in cirrhosis: pathophysiology and management.
Kashani A; Landaverde C; Medici V; Rossaro L
QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
